Request the Kit
No appointment, no waiting, no need to miss work.
Launch
Intimate Care
Discover the new screening method for Cervical Cancer (HPV) and Vaginal Infections (STIs) that is winning over women.
Clara test emerges as an innovative alternative to the conventional collection model, reducing dependence on gynecological infrastructure, equipped rooms, speculums, and mandatory travel to health facilities.
While the traditional method can involve waiting, exposure, discomfort, and complex logistics, Clara test proposes a simpler and more humanized experience for women themselves: collection done in privacy, with practicality and straightforward guidance.
Detects more than
20 types of
vaginal
diseases.
Comfortable design
and ideal size
to
avoid discomfort.
Clara Test was designed to transform feminine care into a simpler, more private and accessible experience. With a sophisticated design, complete kit, and clear instructions, it offers greater autonomy for women who want to take care of their health safely and discreetly.
No appointment, no waiting, no need to miss work.
Women collect at home, without discomfort or embarrassment.
Drop off the sample at the UBS laboratory and wait for the result.
Tests for HPV genotypes 16 and 18, which are associated with approximately 70% of cervical cancer cases, as well as 14 other high-risk genotypes, using PCR.
Screens for the main causative agents of sexually transmitted infections, including: Chlamydia, Neisseria, Trichomonas, Mycoplasma, Ureaplasma, among others.
Assessment of vaginal health, including candidiasis, bacterial vaginosis, and changes in the vaginal microbiota.
Inside the package, you'll find everything you need to complete the process safely and in an organized way.
Clara Test was developed to offer a simpler, more discreet, and safer intimate care experience, aligned with the needs of the modern woman.
Anatomical device designed to facilitate use with greater comfort.
A discreet solution for women who want to care for their intimate health on their own terms.
Clear guidance to make collection more intuitive and reliable.
Cervical cancer and sexually
transmitted
diseases
Delays in collection and testing are increasingly worsening the current situation. When diagnosis doesn't happen at the right time, simple infections progress, risks of complications grow, and transmission becomes easier. The result is clear: more cases, more complex treatments, and greater impact on public health.
HPV and other STIs may not show obvious signs at first, delaying the search for medical guidance.
The sooner a change is identified, the greater the chances of proper follow-up and timely treatment.
Medical follow-up and screening tests are essential steps for reducing risks.
Caring for intimate health should not be
postponed.
Information, prevention, and screening are part of a
safer
and more conscious feminine routine.
Complete kit. Practical collection.
Privacy in
every detail.